BHC — Bausch Health Companies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.59bn
- CA$31.03bn
- $10.27bn
Annual cashflow statement for Bausch Health Companies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -937 | -212 | -611 | -72 | 120 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1,164 | -1,338 | 910 | 329 | 211 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -128 | -396 | -582 | 7 | -219 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 1,426 | -728 | 1,032 | 1,597 | 1,400 |
| Capital Expenditures | -283 | -268 | -272 | -340 | -407 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 692 | -35 | -1,873 | -114 | -188 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 409 | -303 | -2,145 | -454 | -595 |
| Financing Cash Flow Items | -173 | -139 | -106 | -69 | -105 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,513 | -474 | 1,475 | -868 | -742 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 303 | -1,528 | 371 | 239 | 124 |